In a recently funded project involving Boston Children’s Hospital and Northeastern University, chemistry Professors John R. Engen and Roxana Iacob have teamed up with Prof. Timothy A. Springer—a renowned immunologist and structural biologist from Harvard Medical School (HMS) and Boston Children’s Hospital—to uncover the inner-workings of an extremely complex class of proteins.
Dr. Peter Lansbury, Jr. of Brigham & Women’s Hospital and Harvard Medical School talks at the Accelerating Translational Research for Drug Discovery conference at Northeastern University.
I first became interested in drugs to treat brain diseases with I was a pharmacy student at Northeastern in the early 1980s. After I got my PhD in medicinal chemistry at the University of California–San Francisco, I returned to Boston for a post-doctoral fellowship at Harvard Medical School. At the time, I was drawn to research on neurodegenerative diseases, such as Parkinson’s. But by 1987, I switched to neuropsychiatric diseases, and that’s what I’ve been focused on ever since.